✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd.

AKUMS

Market Cap
₹8,446 Cr.
P/E
52.46

Akums Drugs & Pharmaceuticals Ltd.

  • Akums Drugs & Pharma
  • Shilpa Medicare
  • Aarti Pharmalabs
FAQs on Akums Drugs & Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

Akums Drugs & Pharma is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Akums Drugs & Pharma is 52.46, while 3 year average PE is 3.11.
Also latest EV/EBITDA of Akums Drugs & Pharma is 17.43 while 3yr average is 24.61.

View FAQ's On Business
Growth Table
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Balance Sheet
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Cash Flow
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Quarterly Results
  • Akums Drugs & Pharmaceuticals Ltd.
  • Shilpa Medicare
  • Aarti Pharmalabs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Akums Drugs & Pharmaceuticals Ltd. Financials

Balance sheet of Akums Drugs & Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Akums Drugs & Pharma is decreasing.
Latest net debt of Akums Drugs & Pharma is -₹708.14 Crs as of Mar-25.
This is less than Mar-24 when it was -₹62.22 Crs.

The profit is oscillating.
The profit of Akums Drugs & Pharma is ₹161 Crs for Mar 2025, -₹165.45 Crs for Mar 2024 and ₹125 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Akums Drugs & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech